Increased risk of cognitive impairment in patients with diabetes is associated with metformin. - Wikidata - awgldk - TriplyDB

Increased risk of cognitive impairment in patients with diabetes is associated with metformin.

Increased risk of cognitive impairment in patients with diabetes is associated with metformin.

http://www.wikidata.org/entity/Q37193677

about

Diabetes mellitus and metformin in hepatocellular carcinoma The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal Type 2 diabetes and cognitive impairment: contributions from neuroimaging Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain Vitamins and type 2 diabetes mellitus Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Neuroenhancement with vitamin B12-underestimated neurological significance Tang-Nai-Kang alleviates pre-diabetes and metabolic disorders and induces a gene expression switch toward fatty acid oxidation in SHR.Cg-Leprcp/NDmcr rats Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential Diabetes and the brain: issues and unmet needs.Vitamin B12 status in metformin treated patients: systematic review.Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.Benefits of healthy adipose tissue in the treatment of diabetes.Metformin: good or bad for the brain?Metformin in the diabetic brain: friend or foe?Drugs acting on homeostasis: challenging cancer cell adaptation.Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes.Emerging links between type 2 diabetes and Alzheimer's disease Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's Disease Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice Positive association between plasma amylin and cognition in a homebound elderly population.Glucose regulation and cognitive function after bariatric surgery Antidiabetic medications and polypharmacy Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila.Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.Metformin: are potential benefits on cancer risk extended to cancer survival?Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice.Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms.Effect of pioglitazone medication on the incidence of dementia.Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Metabolic control of the proteotoxic stress response: implications in diabetes mellitus and neurodegenerative disorders.Metformin as a Tool to Target Aging.Nutritional strategies to optimise cognitive function in the aging brain.Subchronic metformin pretreatment enhances novel object recognition memory task in forebrain ischemia: behavioural, molecular, and electrophysiological studies.

P2860

Q26741205-8108AB71-C58C-4E5F-986A-9ACF492651A9 Q26777969-53A45373-3706-487F-AF5A-15C05B90BBCE Q26783344-DAC6E114-6C2D-4EF7-8522-B2711D1CF85E Q26825253-61641793-1C80-46E9-9B9A-5ABC1702DFDD Q27003253-86DA3560-D27C-4D4C-9789-EB93CBCD3CFC Q27022122-FD5AC4BA-D043-410F-8253-E7C52E54F639 Q27301246-EA26EE78-D211-4EE1-BF2C-F63D357DA7B0 Q28077202-09B95859-C77F-42E1-BE5F-0DC5F68CF29D Q28304338-DF3A8316-47DC-4A65-8015-C90BAA72BB6A Q28546258-BCC05CAB-0459-431B-B95F-BCB0035C9431 Q29994589-39331E3F-EA5F-46A3-963D-D6573B92852F Q33780337-B4B72B11-36AF-475F-A3BD-A0F46BEA0190 Q33799982-2CD23794-9D62-4AA0-A80C-320D1AFDA79E Q33800802-78AAFE3F-254E-4C28-9E5A-282B91373BE8 Q34023537-B0F9B55A-5BE2-46A4-9824-E0336728416B Q34357962-314642DB-140A-4CE1-928D-E32402D0C76E Q34357977-CB9E5286-0EB7-4D45-84A2-D1C1DE542963 Q34500113-9D39F927-3A34-4CD6-B663-B5867B7467F5 Q35114494-03A5093F-DC7D-47A7-8A0C-B8F94DA7C9B6 Q35691390-389CC2F6-5A2A-4682-9C46-0D6A87C1898D Q35733751-8DE67585-0614-40C9-8ACA-1CE02E5E8A08 Q36771663-76CC5A86-2D6B-4DE1-A85E-A712E95CA71C Q36807576-68733095-A1E8-4A55-887E-A5E5BFC99630 Q36860380-2964C6AF-0489-44E1-AECD-46323876D62A Q36881107-86A27860-2759-433A-8CFF-41725F51D9AF Q37262728-BF88ABCA-D3AA-4D6D-9F97-393D597204CC Q37364862-869E5044-4C2F-42F1-B591-A45E2791AD4C Q37404363-0AE99EFC-9374-49AD-AC35-24DF48837B18 Q37619208-18EBDCFE-405A-4A72-9431-3C4BCA7B2517 Q38234927-D57CB39B-F369-45CD-A257-985058123B9C Q38239648-79A13740-9C29-405F-9DB6-B920AF5B1ABE Q38253639-A922EEC0-9591-44AC-A08D-066E51475D46 Q38414756-D78C142A-E0C2-42E1-806C-D6601529E091 Q38416332-C06A4C95-D6EB-4950-9FD4-6B0B0E96D3AC Q38481462-BDE8E9F6-682A-45D9-9F40-7AFE3C65DFC0 Q38673914-5D5CA2C5-01A5-4134-AC79-C49DF3908F74 Q38862319-12F5F7FC-8EE2-4E9B-A4BB-AA53C0A26FC6 Q38865781-1DA7EFF9-7572-4898-83CC-41B75DECC708 Q38880656-CD0E806C-FEBA-4594-99DC-BD77DF723FBA Q39018499-C090602C-B616-4E91-983E-740EC6DD8ECD

P2860

Increased risk of cognitive impairment in patients with diabetes is associated with metformin.

http://www.wikidata.org/entity/Q37193677

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Increased risk of cognitive im ...... is associated with metformin.

@en

Increased risk of cognitive im ...... is associated with metformin.

@nl

type

label

Increased risk of cognitive im ...... is associated with metformin.

@en

Increased risk of cognitive im ...... is associated with metformin.

@nl

prefLabel

Increased risk of cognitive im ...... is associated with metformin.

@en

Increased risk of cognitive im ...... is associated with metformin.

@nl

P1433

Q37193677-B59DBBE6-D2BE-4E9D-A938-1E197B0890AF

P1476

Q37193677-ADE9776A-960E-4E05-82FF-7975129C5F6E

P2093

Q37193677-0628672B-0EC1-401F-A60F-0472BA34B71C

Q37193677-0A5A80FE-C53D-4369-BA36-16EF7FA581F8

Q37193677-10EF9FCE-D14D-4960-B85E-B19E72C9091E

Q37193677-23A0CC0E-6760-4856-8496-C354087404D4

Q37193677-3254CABC-BCE1-44FA-B682-F1A46870E863

Q37193677-325608DB-09AC-429C-85AF-27B33D427C00

Q37193677-3AD3A1D5-1509-4AFF-A240-53F7414B0EAE

Q37193677-4EB56F74-C243-4303-97B0-241FC7FC35FE

Q37193677-D258E071-A0DF-4160-8EF1-CD1984189FD6

P2860

Q37193677-097AA049-12CA-4100-B405-C717B53B1FAD

Q37193677-17BCF245-E5C0-4166-9FA9-51B87CC39D3D

Q37193677-1A141270-49BE-41F7-A874-E87413C72E97

Q37193677-1BA99683-986C-4A5B-BD8C-736E2DE76118

Q37193677-295AF201-1376-40E9-8974-B595411B73F1

Q37193677-2D1DC392-0FE8-49E2-9B48-915EBDD71BE4

Q37193677-32B6A606-FDBF-4877-977E-574B94E9C8D6

Q37193677-35530AB5-D56E-4FA8-9518-0DB706D17375

Q37193677-483ACCB3-948C-4C6C-A979-B0FD027B3C54

Q37193677-488939A4-1A3E-48FB-9126-BA5FB538E014

P304

Q37193677-3B1CACED-453B-4436-97F6-29B4D1CCA10E

P31

Q37193677-78EC67D1-6428-486F-8EF4-757239DA4F0A

P356

Q37193677-412207A6-DCBF-4E96-AF0D-2023AB4004F6

P407

Q37193677-0CBC9A51-20AE-4D83-9156-C1B82745E90C

P433

Q37193677-8F10B473-829A-4358-8566-4BE85AEC98F4

P478

Q37193677-9708D326-2C2F-4944-A8A7-48E663D345AC

P50

Q37193677-11F63556-CE80-40B1-B8F9-D96C63104F9D

Q37193677-2B26D235-5ED9-4835-B856-B30C49A702ED

Q37193677-461A7641-14B4-481C-BE24-FDBA62F45A56

Q37193677-552D0342-E5CD-4224-BBEF-342FA2EFE35E

Q37193677-8C757968-2931-4308-B1C9-0DB782C75BB2

Q37193677-DBE7B295-D4DD-45B8-B7F5-21C5703CF4F6

Q37193677-FCDFC8DB-5678-47DD-BFD4-C7DA83F123A9

P577

Q37193677-53E28AFC-D0BF-467F-9450-E971AB209644

P5875

Q37193677-1760A598-002B-4951-8380-0DAB7181A4A2

P698

Q37193677-A605EB66-3614-4491-902A-8BD54FCECD52

P921

Q37193677-63B97699-C68F-4E61-8D07-83BC27740A56

Q37193677-9567DB01-8069-4375-84C9-7BD7887E4E79

P932

Q37193677-3C96B6F7-9E42-4443-84B9-A8C4FE1B1838

P356

P1433

P1476

Increased risk of cognitive im ...... is associated with metformin.

@en

P2093

AIBL Investigators

http://www.w3.org/2001/XMLSchema#string

Alastair G Mander

http://www.w3.org/2001/XMLSchema#string

Christopher Rowe

http://www.w3.org/2001/XMLSchema#string

David A Watters

http://www.w3.org/2001/XMLSchema#string

David Ames

http://www.w3.org/2001/XMLSchema#string

Eileen M Moore

http://www.w3.org/2001/XMLSchema#string

Karyn Boundy

http://www.w3.org/2001/XMLSchema#string

Michael Woodward

http://www.w3.org/2001/XMLSchema#string

Ross P Carne

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.

Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin.

Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy.

Diabetes is associated with increased rate of cognitive decline in questionably demented elderly.

P304

2981-2987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC13-0229

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Mark A. Kotowicz

Cassandra Szoeke

Kathryn A Ellis

P577

2013-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256484291

http://www.w3.org/2001/XMLSchema#string

P698

24009301

http://www.w3.org/2001/XMLSchema#string

P921

P932

3781568

http://www.w3.org/2001/XMLSchema#string